Research & Trials

The ECWM is establishing a distinctive platform for launching large-scale and innovative clinical trials focused on the rare disease of WM. Currently, multiple trials are underway, offering patients access to new treatment options within rigorously controlled clinical environments. These include both single-arm and randomized prospective studies.

By combining clinical and translational research efforts, the consortium aims to advance our knowledge of the molecular and cellular biology of WM. This multidisciplinary approach is critical for tackling complex diseases like WM and holds promise for a better understanding of the underlying conditions.

Our research goals seek to understand WM comprehensively, addressing various disciplines and approaches such as genetics and epigenetics to microenvironment interactions and minimal residual disease detection.  All these efforts pursue the final goal to translate these findings into a better clinical care of WM patients.